Tuesday, January 30, 2007

Thailand Dilutes Two More Patent Monopoly

Thailand Ministry of Public Health has diluted Sanofi’s patent monopoly for anti-platelet drug --- Clopidogrel bisulphate and also Abbott’s patent monopoly for second-line anti-retroviral drug --- Lopinavir and ritonavir by issuing compulsory license which will allow Thailand to import and/or local production of generic versions. Earlier in December 2006, Merck’s Efavirenz was issued compulsory license by Thailand Government.

No comments:

Post a Comment